EUVIMEDEUVIMED entdecken
Crossref

Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy

Cunguo Chen iD, Murong Hu, Yunyun Cao, Binbin Zhu, Jiashe Chen, Yashi Li, Junyi Shao, Sen Zhou, Pengfei Shan, Chen Zheng, Zhongyu Li iD, Zhiming Li

Biomacromolecules · 12.06.2023 · 24 (6) · 2790-2803

DOI: 10.1021/acs.biomac.3c00196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 01.05.2023. Verfasst von Cunguo Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang 325200, P. R. China. Hauptthemen laut MEDLINE: Chitosan, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic dinucleotides (CDNs) are a promising class of immune agonists that trigger the stimulator of interferon genes (STING) to activate both innate and acquired immunity. However, the efficacy of CDNs is limited by drug delivery barriers. Therefore, we developed a combined immunotherapy strategy based on injectable reactive oxygen species (ROS)-responsive hydrogels, which sustainably release 5,6-dimethylxanthenone-4-acetic acid (DMXAA) as known as a STING agonist and indocyanine green (ICG) by utilizing a high level of ROS in the tumor microenvironment (TME). The STING agonist combined with photothermal therapy (PTT) can improve the biological efficacy of DMXAA, transform the immunosuppressive TME into an immunogenic and tumoricidal microenvironment, and completely kill tumor cells. In addition, this bioreactive gel can effectively leverage local ROS to facilitate the release of immunotherapy drugs, thereby enhancing the efficacy of combination therapy, improving the TME, inhibiting tumor growth, inducing memory immunity, and protecting against tumor rechallenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanNeoplasmsHumansImmunotherapyMembrane ProteinsPhotothermal TherapyReactive Oxygen SpeciesTumor Microenvironment

Substanzen

ChitosanMembrane ProteinsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang 325200, P. R. China.
  • Department of Dermatology and Venereology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P. R. China.
  • Department of Dermatology and Venereology, Hangzhou Third Hospital, Hangzhou, Zhejiang 321000, P. R. China.
  • Nursing Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P. R. China.
  • College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325027, P. R. China.
  • Department of Breast Cancer Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P. R. China.

ORCID-Profile: Cunguo Chen, Zhongyu Li

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Chen, C., Hu, M., Cao, Y., Zhu, B., Chen, J., Li, Y., Shao, J., Zhou, S., Shan, P., Zheng, C., Li, Z., & Li, Z. (2023). Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy. Biomacromolecules, 24(6), 2790-2803. https://doi.org/10.1021/acs.biomac.3c00196

Vancouver

Chen C, Hu M, Cao Y, Zhu B, Chen J, Li Y, et al. Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy. Biomacromolecules. 2023;24(6):2790-2803. doi:10.1021/acs.biomac.3c00196

BibTeX
@article{Chen2023,
  author = {Chen, Cunguo and Hu, Murong and Cao, Yunyun and Zhu, Binbin and Chen, Jiashe and Li, Yashi and Shao, Junyi and Zhou, Sen and Shan, Pengfei and Zheng, Chen and Li, Zhongyu and Li, Zhiming},
  title = {Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy},
  journal = {Biomacromolecules},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {2790--2803},
  doi = {10.1021/acs.biomac.3c00196}
}
Kostenlos starten →